Coronary artery ectasia--is it time for a reappraisal?

P Ramappa1, A Kottam, H Kuivanemi

  • 1Division of Cardiology, Department of Internal Medicine, Wayne State University, Detroit, Michigan 48201, USA.

Clinical Cardiology
|May 12, 2007
PubMed

Insights

Coronary artery ectasia (CAE) is a vascular condition often linked to atherosclerosis and genetic factors. Further research is needed to understand its causes and optimal treatment, including anticoagulation.

Area of Science:

  • Cardiology
  • Vascular Biology

Background:

  • Coronary artery ectasia (CAE) is a recognized condition found during cardiac catheterization.
  • Its underlying causes (etiopathogenesis) are not well understood.
  • CAE is often associated with obstructive coronary artery disease and aortic aneurysms, suggesting links to atherosclerosis and genetic factors.

Purpose of the Study:

  • To review the current understanding of coronary artery ectasia.
  • To discuss its potential causes, including atherosclerosis and genetic predispositions.
  • To highlight the clinical implications and areas needing further research.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • It discusses findings from diagnostic cardiac catheterization.
  • It explores associations with other cardiovascular conditions.

Main Results:

  • Coronary artery ectasia is frequently associated with obstructive coronary artery disease.
  • Genetic abnormalities are implicated due to its association with aortic aneurysm.
  • Disrupted blood flow in CAE can lead to thrombus formation.

Conclusions:

  • Coronary artery ectasia is not always a benign condition.
  • The role of long-term anticoagulation in CAE management requires further investigation.
  • Increasing use of noninvasive imaging may lead to a higher reported incidence of CAE.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...